"DIREGL07563 RATIONAL studyAn obseRvationAl registry To assess urInary albumin evOlution in Saudi hyperteNsive patients with the current treatment local ALgorithm "

drug protocol number
3
drug sponsor
SANOFI
drug study
APROVEL / Irbesartan
drug trial site
King Abdulaziz University Hospital (Jeddah)
drug status
Ongoing
drug phase